RRML - Resistance to antiretroviral therapy in HIV infected patients

Main page
News
RJLabM Credits
Archive
- Current issue
- Ahead of print
- List of published issues
- 2025
  - Nr.1/2025
  - Nr.2/2025
  - Nr.3/2025
- 2024
  - Nr.4/2024
  - Nr.3/2024
  - Nr.2/2024
  - Nr.1/2024
  - Supplement 1/2024
- 2023
  - Nr.4/2023
  - Nr.3/2023
  - Nr.2/2023
  - Nr.1/2023
  - Supplement 1/2023
- 2022
  - Nr.4/2022
  - Nr.3/2022
  - Nr.2/2022
  - Nr.1/2022
  - Supplement 1/2022
- 2021
  - Nr.4/2021
  - Nr.3/2021
  - Nr.2/2021
  - Nr.1/2021
- 2020
  - Nr.4/2020
  - Nr.3/2020
  - Nr.2/2020
  - Nr.1/2020
  - Supplement 1/2020
- 2019
  - Nr.4/2019
  - Nr.3/2019
  - Nr.2/2019
  - Nr.1/2019
  - Supplement 1/2019
- 2018
  - Nr.4/2018
  - Nr.3/2018
  - Nr.2/2018
  - Nr.1/2018
  - Supplement 1/2018
  - Supplement 2/2018
  - Supplement 3/2018
- 2017
  - Nr.4/2017
  - Nr.3/2017
  - Nr.2/2017
  - Nr.1/2017
  - Supplement 1/2017
- 2016
  - Nr.4/2016
  - Nr.3/2016
  - Nr.2/2016
  - Nr.1/2016
  - Supplement 1/2016
- 2015
  - Nr.4/2015
  - Nr.3/2015
  - Nr.2/2015
  - Nr.1/2015
  - Supplement 1/2015
- 2014
  - Nr.4/2014
  - Nr.3/2014
  - Nr.2/2014
  - Nr.1/2014
  - Supplement 1/2014
- 2013
  - Nr.4/2013
  - Nr.3/2013
  - Nr.2/2013
  - Nr.1/2013
  - Supplement 1/2013
- 2012
  - Nr.4/2012
  - Nr.3/2012
  - Nr.2/2012
  - Nr.1/2012
  - Supplement 1/2012
- 2011
  - Nr.4/2011
  - Nr.3/2011
  - Nr.2/2011
  - Nr.1/2011
  - Supplement 1/2011
- 2010
  - Nr.4/2010
  - Nr.3/2010
  - Nr.2/2010
  - Nr.1/2010
  - Supplement 1/2010
- 2009
  - Nr.4/2009
  - Nr.3/2009
  - Nr.2/2009
  - Nr.1/2009
  - Supplement 1/2009
- 2008
  - Nr.4/2008
  - Nr.3/2008
  - Nr.2/2008
  - Nr.1/2008
  - Supplement 1/2008
- 2007
  - Nr.4/2007
  - Nr.3/2007
  - Nr.2/2007
  - Nr.1/2007
- 2006
  - Nr.4/2006
  - Nr.3/2006
  - Nr.2/2006
  - Nr.1/2006
- 2005
  - Nr.1/2005
Instructions for authors
Online applications
- Send an article
- Online payments
Editorial
About us
Links

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12

Top 10 downloaded articles - September 2025 -

Romanian Review of Laboratory ...	17
ATM rs189037 polymorphism: A p...	14
The diagnostic value of lipopr...	12
Species distribution and resis...	9
Assessment of preoperative and...	6
Emergence of Carbapenemase-pro...	6
Monitoring CAR T cells in peri...	6
Correlation between fecal biom...	6
Association of neutrophil-to-l...	6
CALLY index, but not HALP scor...	6

Concept, Design & Programming
Dr. Adrian Man

Nr. 6(1)/2007

Resistance to antiretroviral therapy in HIV infected patients

Márta Andrea Fodor, Minodora Dobreanu, Rodica Pascu, Monica Sabău

Abstract:

Purpose: to determine the frequency of resistance mutations in patients treated in Mures Regional Center of Monitoring of HIV Infection. Material and methods: We included in our study 24 patients with HIV infection. The resistance testing was performed by viral genotyping in the Laboratory of Molecular Diagnosis of Infectious Diseases Institute “Prof. Matei Balş”, Bucharest. We also followed the age, the gender, the provenience of patients and the number modifications in CD4 and CD8 lymphocytes and viral load before and after testing. Results: we observed an increase in number of CD4, CD8 lymphocytes, in the CD4/CD8 ratio and a decrease in viral load. The most frequent mutations of resistance were: in the RT gene: M148V, M41L, T215Y, D67N, K70R, Y181C, K103N, and in the PR gene: L10I, I54V, L10V, K20R, M36I, V82A. We observed a great number of resistance/ intermediate sensibility for the following drugs: IDV, RTV, DLV, EFV, NVP, AZT, ABC, NFV, ddC, SQV. Conclusions: repeated, periodical testing of antiretroviral resistance in the ARV treated pactients is necessary for optimal treatment of these patients.

Download full text PDF
(742 KB)

Fodor MA, Dobreanu M, Pascu R, Sabău M. Resistance to antiretroviral therapy in HIV infected patients. Rev Romana Med Lab. 2007;6(1):15-24